A randomized controlled study of the efficacy of tadalafil monotherapy versus combination of tadalafil and mirabegron for the treatment of persistent overactive bladder symptoms in men presenting with lower urinary tract symptoms (CONTACT Study).
Tomonori YamanishiKanya KagaKoichi SakataTeruhiko YokoyamaShinji KageyamaMiki FuseShoji TokunagaPublished in: Neurourology and urodynamics (2020)
The effect of tadalafil/mirabegron combination therapy on relieving OAB symptoms appeared to be greater than that of tadalafil monotherapy and can be safely used.